4//SEC Filing
Olson William C 4
Accession 0001441844-11-000014
CIK 0000835887other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:50 AM ET
Size
11.7 KB
Accession
0001441844-11-000014
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Tax Payment
Common Stock
2011-04-01$6.29/sh−2,075$13,052→ 47,846 total - Exercise/Conversion
ESPP (right to buy)
2011-04-01−2,373→ 0 totalExercise: $5.05From: 2011-04-01Exp: 2011-04-01→ Common Stock (2,373 underlying) - Award
ESPP (right to buy)
2011-04-01+2,057→ 2,057 totalExercise: $6.18From: 2011-10-01Exp: 2011-10-01→ Common Stock (2,057 underlying) - Exercise/Conversion
Common Stock
2011-04-01$5.05/sh+2,373$11,984→ 49,921 total
Footnotes (5)
- [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F2]Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
- [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
- [F5]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the exercise date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001327414
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 9:50 AM ET
- Size
- 11.7 KB